Angiographic Catheters Market Report 2026

Angiographic Catheters Market Overview

• Angiographic Catheters market size has reached to $1.42 billion in 2025 • Expected to grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Heart Surgeries Fuel Growth In The Angiographic Catheter Market • Market Trend: Innovations In Angiographic Catheters Enhance Patient Safety And Procedural Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angiographic Catheters Market?

Angiographic catheters are specialized medical devices used in angiography to diagnose and treat conditions within the blood vessels. These thin, flexible tubes are inserted into the vascular system to inject contrast dye, enabling real-time X-ray images (angiograms) of arteries, veins, and heart chambers, helping doctors assess blockages, aneurysms, or other vascular issues. The main product types of angiographic catheters are conventional catheters, drug-eluting balloon catheters, cutting balloon catheters, and scoring balloon catheters. Conventional catheters referred to as non-coated catheters, are the traditional design for intermittent urinary catheters. The technologies are x-ray, magnetic resonance angiography (MRA), and computed tomography (CT), and the different applications are coronary, endovascular, neurology, oncology, and others. It is used by various end users, such as hospitals, ambulatory surgical centers, cardiac centers, brain centers, specialty clinics, and others.

What Is The Angiographic Catheters Market Growth Forecast?

The angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to development of drug eluting and scoring balloon catheters, integration with mra and ct technologies, rising demand from neurology and oncology interventions, expansion of cardiac and specialty centers, adoption of smart catheter systems with real-time imaging. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of drug eluting and cutting balloon catheters, growth in coronary and endovascular applications, integration of advanced imaging technologies with catheters, focus on patient safety and reduced procedure time.

Global Angiographic Catheters Market Segmentation

1) By Product: Conventional Catheters, Drug Eluting Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters 2) By Technology: X-Ray, Magnetic Resonance Angiography (MRA), Computed Tomography (CT) 3) By Application: Coronary, Endovascular, Neurology, Oncology, Other Applications 4) By End User: Hospital, Ambulatory Surgical Centers, Cardiac Centers, Brain Centers, Specialty Clinics, Other End Users Subsegments: 1) By Conventional Catheters: Diagnostic Catheters, Guiding Catheters, Balloon Catheters, Drug Eluting Balloon Catheters 2) By Drug Eluting Balloon Catheters: Paclitaxel-Eluting Balloons, Sirolimus-Eluting Balloons 3) By Cutting Balloon Catheters: Standard Cutting Balloons, Specialty Cutting Balloons 4) By Scoring Balloon Catheters: Semi-Compliant Scoring Balloons, Non-Compliant Scoring Balloons

What Is The Driver Of The Angiographic Catheters Market?

The rising number of heart surgeries is expected to propel the growth of the angiographic catheters market going forward. Heart surgery, also known as cardiac surgery, encompasses a variety of surgical procedures performed on the heart or the great vessels. The number of heart surgeries is increasing due to several reasons, such as an aging population, a rise in cardiovascular diseases, advancements in medical technology, and better surgical outcomes. Angiographic catheters are used in heart surgeries to visualize coronary arteries, enabling precise diagnosis and treatment of blockages or abnormalities. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 compared to 2023. Therefore, the rising number of heart surgeries is driving the growth of the angiographic catheters industry.

Key Players In The Global Angiographic Catheters Market

Major companies operating in the angiographic catheters market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc.

Global Angiographic Catheters Market Trends and Insights

Major companies operating in the angiographic catheters market are focusing on developing advanced technologies such as fiber optic realShape (FORS) technology to enable real-time, high-resolution 3D imaging during catheter navigation, reducing radiation exposure and enhancing precision in complex vascular procedures. Fiber Optic RealShape (FORS) technology is an advanced imaging platform that utilizes light reflected through optical fibers within medical devices to create real-time, high-resolution 3D visualizations of their shapes inside the body, enabling precise navigation during minimally invasive procedures. For instance, in February 2024, Philips Healthcare, a Netherlands-based health technology company, launched the LumiGuide, a light-based, radiation-free catheter guidance system for endovascular aortic procedures. Utilizing fiber optic realShape (FORS) technology, LumiGuide generates real-time, high-resolution, 3D images of devices within the body, enabling navigation without the need for X-ray angiography. Its key features include improved 3D visualization of catheters, reduced radiation exposure, immediate feedback on device orientation, and AI-assisted registration for enhanced accuracy during complex procedures. It is available in select hospitals across Europe and the U.S., LumiGuide aims to bolster patient safety and procedural efficiency.

What Are Latest Mergers And Acquisitions In The Angiographic Catheters Market?

In October 2023, Cordis Medical Device Co., Ltd., a US-based medical company, acquired MedAlliance Swiss Medical Technology for an undisclosed amount. This acquisition will enhance Cordi's ability to accelerate access to this advanced technology, thereby improving patient care in the cardiovascular field. The acquisition aims to enhance Cordis' portfolio in these areas, providing innovative solutions for treating vascular diseases. MedAlliance Swiss Medical Technology is a Switzerland-based developer of angiographic catheters.

Regional Outlook

North America was the largest region in the angiographic catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Angiographic Catheters Market?

The angiographic catheters market consists of sales of catheter shafts, tips, lumens, connectors, and balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.